Compare XOMA & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XOMA | WHF |
|---|---|---|
| Founded | 1981 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.2M | 162.2M |
| IPO Year | N/A | 2012 |
| Metric | XOMA | WHF |
|---|---|---|
| Price | $25.14 | $7.35 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | ★ $63.25 | $7.75 |
| AVG Volume (30 Days) | 81.3K | ★ 180.4K |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 23.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.82 | 0.42 |
| Revenue | $47,106,000.00 | ★ $76,339,000.00 |
| Revenue This Year | $77.23 | N/A |
| Revenue Next Year | $17.97 | N/A |
| P/E Ratio | $30.70 | ★ $17.85 |
| Revenue Growth | ★ 118.02 | N/A |
| 52 Week Low | $18.35 | $6.39 |
| 52 Week High | $39.92 | $11.31 |
| Indicator | XOMA | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 50.58 |
| Support Level | $29.60 | $7.16 |
| Resistance Level | $34.79 | $7.84 |
| Average True Range (ATR) | 1.89 | 0.18 |
| MACD | -0.53 | 0.01 |
| Stochastic Oscillator | 5.70 | 40.79 |
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.